D-Wave Quantum (Nasdaq: QBTS) reported Q3 2026 revenue of $4.51 million on November 10, up 21% year over year, beating the $4.36 million consensus. The adjusted EPS loss of $0.13 against an expected $0.10 dragged the stock down in the next session. That reaction is worth examining, because the numbers investors chose to sell on are not the ones that actually matter here.
Why This Stock Now
Remaining performance obligations, the contractual revenue backlog, surged 1,221% year over year to $38.3 million. Nine-month bookings reached $37.4 million, a 611% increase, driven by enterprise expansion and integration of Quantum Circuits. Approximately 59% of that backlog is expected to convert to revenue within 12 months. The company finalized a definitive award agreement with the U.S. Department of Commerce for up to $100 million in CHIPS and Science Act funding, structured in milestone-based tranches, with the government taking a minority, non-controlling equity stake. The initial tranche made available was $53.55 million. D-Wave holds $503.4 million in cash and marketable securities.
The Business
D-Wave is the only publicly listed quantum computing company operating a dual-platform model, offering both quantum annealing systems and gate-model quantum computers. That matters because annealing systems solve a different class of optimization problems than gate-model machines, and enterprises often need both. QCaaS subscription revenue grew 56% year over year in Q3 to $2.2 million. Professional services revenue grew 318% to $2.0 million, driven by a $10 million two-year engagement with a Fortune 100 customer. NTT DOCOMO used D-Wave technology to cut location registration signals by 65.3% at the daily peak. SkyWater Semiconductor ran a proof-of-technology that reduced lot delays by up to 30%.
The roadmap targets a 100,000-qubit annealing system around 2031 and a gate-model system targeting 100 logical qubits by 2032, supported by the CHIPS Act award.
Why Wall Street Is Paying Attention
Quantum computing stocks trade almost entirely on story until revenue catches up with the promise. D-Wave is further along than most: it has paying commercial customers, production deployments, and government validation. The CHIPS Act award is performance-linked, which means funding is tied to technical milestones rather than arriving as an unconditional grant. That structure reduces the risk of funding continuing unchanged if progress stalls.
The stock is down year to date despite the bookings acceleration and government backing, which puts it in the unusual position of a company whose news flow has improved materially while the price has not.
What’s Driving the Opportunity
The RPO conversion rate is the number to watch. If 59% of $38.3 million converts within 12 months, D-Wave adds roughly $22 million to revenue over the next four quarters, nearly doubling its current annual run rate. The pipeline grew more than 75% from Q2 to Q3. With $503 million in cash and up to $100 million in CHIPS funding available against an adjusted EBITDA loss of $37.7 million per quarter, the runway is long enough to reach meaningful scale if bookings continue accelerating.
What Could Go Wrong
The adjusted EBITDA loss expanded 83% year over year to $37.7 million. That is the speed at which the cash cushion depletes if bookings stop growing. Q3 bookings of $1.9 million fell 19% from the prior year, suggesting the nine-month number is heavily weighted toward a Florida Atlantic University system sale and the Fortune 100 contract, neither of which is recurring in the same form. Gross margin compressed to 52.9% from 71.4% a year earlier. The CHIPS award includes an equity component: D-Wave agreed to issue $100 million of common stock to the Commerce Department, which is dilutive. And the gap between $4.5 million in quarterly revenue and a market cap that still reflects significant future optionality is wide enough to close painfully fast if enterprise adoption stalls.
The Bottom Line
D-Wave is not a stock for investors who need to see earnings. It is a stock for investors who believe quantum computing crosses into commercial relevance before the cash runs out, and who think D-Wave’s dual-platform differentiation and U.S. government backing give it a better path than peers. The RPO surge is real. The enterprise engagements are real. The award is real. The revenue is not yet large enough to validate any of it at scale, and that is the bet. For the right portion of a portfolio, the risk-reward here is at least as interesting as most AI infrastructure names trading at far higher multiples on far stronger revenues.
